2022
DOI: 10.3389/fgene.2022.983283
|View full text |Cite
|
Sign up to set email alerts
|

A homozygous variant in the GPIHBP1 gene in a child with severe hypertriglyceridemia and a systematic literature review

Abstract: Background: Due to nonspecific symptoms, rare dyslipidaemias are frequently misdiagnosed, overlooked, and undertreated, leading to increased risk for severe cardiovascular disease, pancreatitis and/or multiple organ failures before diagnosis. Better guidelines for the recognition and early diagnosis of rare dyslipidaemias are urgently required.Methods: Genomic DNA was isolated from blood samples of a Pakistani paediatric patient with hypertriglyceridemia, and from his parents and siblings. Next-generation sequ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 72 publications
0
3
0
Order By: Relevance
“…Other clinical presentations include eruptive xanthoma, lipemia retinalis and hepatomegaly. 11, 12,13,14 The most serious complication in FCS is the development of acute pancreatitis. 11, 14 Other clinical complications include chylothorax, cerebral thrombophlebitis, lipid encephalopathy.…”
Section: Discussionmentioning
confidence: 99%
“…Other clinical presentations include eruptive xanthoma, lipemia retinalis and hepatomegaly. 11, 12,13,14 The most serious complication in FCS is the development of acute pancreatitis. 11, 14 Other clinical complications include chylothorax, cerebral thrombophlebitis, lipid encephalopathy.…”
Section: Discussionmentioning
confidence: 99%
“…Genetic analysis was conducted at the University Children’s Hospital, Ljubljana, Slovenia, following a previously established protocol in Slovenia ( 14 ).…”
Section: Methodsmentioning
confidence: 99%
“…The following genes were included in the analysis: ABCA1, ABCG5, ABCG8, ALMS1, APOA1, APOA5, APOB, APOC2, APOC3, APOE, CREB3L3, GPIHBP1, LDLR, LDLRAP1, LIPA, LMF1, LPL, and PCSK9 . candidate pathogenic variants identified through NGS following previously described protocol ( 14 ) were validated using Sanger sequencing.…”
Section: Methodsmentioning
confidence: 99%